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The data and results in this series of papers on chemical transformation of BALB/c-3T3 cells detail a substantial effort to understand the uses and limitations of this methodology in identifying chemicals with carcinogenic potential. This project is an important portion of an effort supported by the National Toxicology Program (NTP) to develop, evaluate, and validate various in vitro and in vivo methods that may be used to identify properties of chemicals that can predict carcinogenic activity or other toxicological effects. These efforts have the goals of improving our understanding of the nature of carcinogenic potential, understanding carcinogenic and toxicologic mechanisms, and identifying chemical properties that have predictive value and thereby reducing our dependence on the use of long-term rodent bioassays to define these end points.
Among the methodologies that have been evaluated by the NTP are several assays that detect chemical-induced transformation in mammalian cells. Transformation assays assessed in this program used primary Syrian hamster embryo (SHE) cells, primary human fibroblasts, A31-1-13 clone of BALB/c-3T3 cells, and viral-vectored genes or viral-infected cells such as Simian adenovirus (SA7) infection of SHE or rat embryo fibroblasts infected with the Rauscher murine leukemia virus. These papers present several important conclusions regarding the BALB/c-3T3 transformation assay.
There are some general conclusions that can be derived regarding mammalian cell transformation based on experience with these methodologies. Each method presents unique characteristics and positive and negative properties. It is important to emphasize that the context in which the activities and value of these systems has been judged. database. There are, therefore, many other potential uses and application of these methods that are not considered by this form of evaluation. Each assay system or methodology is unique because the cell systems differ in a variety of characteristics depending on whether they are primary or established cultures and whether they have undergone genetic changes such as aneuploidy, etc. All of them have undergone a variety of phenotypic changes involved in adaptation to growth in cell culture, and they vary considerably in their endogenous capacity to metabolize chemicals. Some of the cells possess an extended life span in culture; that is, they are cell lines, whereas other cultures such as the primary SHE cells must undergo conversion during extended growth in culture to demonstrate tumorigenic potential. The measured end point for transformation or the characteristic phenotypic properties of transformed cells also vary but ultimately must be related to the ability of the cells to produce neoplastic growth in suitable recipient animals. Most of the protocols that use these cells for transformation assays are predicted upon various acute exposure regimens, sometimes using exogenous sources of metabolizing systems (e.g., liver S9 fractions).
The overall implications of the results from cell transformation assay investigations that we have published are that there was not a precise correspondence of the ability of chemicals to induce tumors in rodent bioassays and to transform cells in vitro. Furthermore, there was not a precise correlation of chemicals that induce cell transformation in different assay systems. However, in general, the ability of chemicals to transform cells in vitro was most highly correlated with other genetic toxicity or mutagenic potential generally related to electrophilic properties of the chemicals. Nevertheless, transformation assays have detected some chemicals that induced tumors and are not commonly considered to be genotoxic.
In rodents, chemical carcinogens produce a variety of effects that show a range of biological properties. Many show independence from sex, species, and tissue restraints; that is, some chemicals cause tumors across these barriers, while other chemicals show very specific species, sex, and tissue neoplasia. 
